Current role
Eric Karas
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Karas
ARS Pharmaceuticals, Inc. reported in an 8-K filed November 8, 2022 that Eric Karas was appointed Chief Commercial Officer, effective April 1, 2022. ARS Pharmaceuticals, Inc. reported in an 8-K filed November 8, 2022 that Eric Karas was appointed Chief Commercial Officer, effective November 8, 2022.
“Executive shall serve as the Company's Chief Commercial Officer, reporting to the Company's Chief Executive Officer.”
“At the effective time of the Merger, the Company's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
ARS Pharmaceuticals, Inc. (SPRY)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ARS Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Donn Casale CEO, Board Member
- Rich Lowenthal CEO
- Richard Lowenthal CEO
- Pratik Shah Chairman
- Kathleen Scott CFO
- Russ Hawkinson CFO
- Brian Dorsey COO
- Brenton L. Saunders Board Member
- Jonathan S. Leff Board Member
- Laura Shawver Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.